|  |



Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria

Company to receive approximately $7 million in funding from the Gates Foundation to use its srRNA platform to develop malaria and HIV candidates ...


View article...


Top stories of the last 30 days